Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 53

Results For "Super"

589 News Found

HealthPlix releases Prescription Summary Dashboard for doctors
Healthcare | December 15, 2021

HealthPlix releases Prescription Summary Dashboard for doctors

Doctors can now analyse their historical prescriptions within a few clicks enabling them to identify different cohorts of patients and the treatment given to them


Kaka-Ba hospital surgeons perform surgery to correct spine disorder
Hospitals | December 13, 2021

Kaka-Ba hospital surgeons perform surgery to correct spine disorder

Scoliosis is a disorder of the spine, and its surgeries are generally done only in large hospitals in big cities.


Wipro-GE unveils B2B e-commerce platform for medical equipment
Medical Device | December 07, 2021

Wipro-GE unveils B2B e-commerce platform for medical equipment

It is an extension of GE Healthcare’s online service delivery enterprise Service Shop


Narayana Hrudayalaya to open a hospital in Punjab
Hospitals | December 05, 2021

Narayana Hrudayalaya to open a hospital in Punjab

The hospital is scheduled to open in 2024 with a bed capacity of 225


Eris signs JV with MJ Biopharm to supply insulin in India
News | December 05, 2021

Eris signs JV with MJ Biopharm to supply insulin in India

MJ will be paid a one-time lumpsum licence fee of Rs 15 crore


North America accounts for 50 % of generic pharma market
News | December 03, 2021

North America accounts for 50 % of generic pharma market

Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively


U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib
Biotech | November 30, 2021

U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib

Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)


AMPATH launches its pathology laboratory in Mumbai
Clinical Trials | November 29, 2021

AMPATH launches its pathology laboratory in Mumbai

The company has has 10 existing labs in India


Sputnik Light in India by December: RDIF
News | November 25, 2021

Sputnik Light in India by December: RDIF

One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster


Medical devices industry needs reforms:  Mehernosh Daruwalla, Founder & MD, Lotus Surgicals
interviews | November 24, 2021

Medical devices industry needs reforms: Mehernosh Daruwalla, Founder & MD, Lotus Surgicals

The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector